Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Myricitrin** is a naturally occurring glycosyloxyflavone, specifically the 3-O-rhamnoside of myricetin, with molecular formula **C21H20O12** and CAS number **17912-87-7**[2]. It is isolated from plants such as Myrica cerifera and Myrtus communis. Myricitrin exhibits **potent antioxidant** and **radical scavenging** activities, together with reported **antimutagenic** and **anti-allergic** effects[2]. Its biological actions include inhibition of mutagenicity (including inhibition against agents like nifuroxazide, aflatoxin B1, and H2O2) and general cytoprotective effects. Myricitrin is a reference standard in chemical analysis of herbal preparations and is found in several food and medicinal plant extracts[2]. The mechanism of action is primarily through scavenging reactive oxygen species, reducing oxidative stress, and potentially modulating inflammatory responses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on myricitrin.